ResMed Inc. (LON: 0KW4)

Market Cap	29.49B
Revenue (ttm)	3.59B
Net Income (ttm)	830.32M
Shares Out	n/a
EPS (ttm)	5.63
PE Ratio	35.52
Forward PE	n/a
Dividend	1.58 (0.64%)
Ex-Dividend Date	Nov 7, 2024

Volume	475
Average Volume	998
Open	252.01
Previous Close	246.59
Day's Range	242.88 - 252.01
52-Week Range	132.67 - 252.01
Beta	0.69
RSI	63.12
Earnings Date	Jan 23, 2025

About ResMed

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on de...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1989
• Employees: 9,980
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0KW4

Financial Performance

In 2024, ResMed's revenue was $4.69 billion, an increase of 10.95% compared to the previous year's $4.22 billion. Earnings were $1.02 billion, an increase of 13.75%.

Financial numbers in USD